Suppr超能文献

糖树状大分子:揭示糖编码的新型糖表位类似物。以乳腺癌MUC1糖蛋白的T抗原标记物为例的研究。

Glycodendrimers: novel glycotope isosteres unmasking sugar coding. case study with T-antigen markers from breast cancer MUC1 glycoprotein.

作者信息

Roy René, Baek Myung-Gi

机构信息

Centre for Research in Biopharmaceuticals, Department of Chemistry, University of Ottawa, ON, Canada.

出版信息

J Biotechnol. 2002 May;90(3-4):291-309. doi: 10.1016/s1389-0352(01)00065-4.

Abstract

Glycodendrimers are relatively novel synthetic biomacromolecules that are made of biologically relevant carbohydrate ligands constructed at the periphery of a wide range of highly functionalized and repetitive scaffolds having varied molecular weights and structures. They were aimed to fill the gap between glycopolymers, having generally dispersed higher molecular weight, and small glycoclusters, in the study of multivalent carbohydrate protein interactions. In a way, glycodendrimers, with their spheroidal or dendritic (wedge) type structures, were initially designed as bioisosteres of cell surface multiantennary glycans. Taken as a curiosity and elegant molecules at their beginning, they are now considered as potent inhibitors of microbial adhesins. They have also been shown to play some roles in signal transduction and in receptor cross-linking. This brief report will describe advances that have been made toward the syntheses of a range of glycodendrimers bearing the immunodominant T-antigen disaccharide [beta-D-Gal-(1-3)-alpha-D-GalNAc] found on malignant cells of carcinomas, particularly related to breast cancer. This antigen, usually cryptic on healthy tissues, is greatly increased on cancer cells as a result of aberrant glycosylation. It is considered to be an important cancer marker. The high incidence of these carcinomas to invade other tissues such as lymph nodes, lung, and liver by metastasis was one of the arguments raised to generate T-antigen dendrimers that might have the potential to block the receptor sites following surgery. The synthesis of the T-antigen disaccharide will be briefly described, followed by the elaboration of neoglycoproteins and glycopolymers used to raise monoclonal antibodies against the T-antigen and for screening purpose, respectively. Scaffolds made of poly(amidoamine) (PAMAM), poly(propylene imine), N,N'-bis(acrylamido)acetic acid, and finally hyperbranched L-lysine were used to construct relatively small glycodendrimers bearing T-antigen moieties. Few glycodendrimers were also linked to fluorescein and biotin probes to generate ligands that can be used to detect T-Ag receptor sites.

摘要

糖树状大分子是相对新颖的合成生物大分子,由生物相关的碳水化合物配体构成,这些配体构建在一系列具有不同分子量和结构的高度功能化且重复的支架外围。在多价碳水化合物 - 蛋白质相互作用的研究中,它们旨在填补通常具有较高分散分子量的糖聚合物与小分子糖簇之间的空白。从某种程度上讲,具有球状或树枝状(楔形)结构的糖树状大分子最初被设计为细胞表面多天线聚糖的生物电子等排体。一开始它们被视为新奇且精巧的分子,如今则被认为是微生物黏附素的有效抑制剂。它们还被证明在信号转导和受体交联中发挥着一些作用。本简要报告将描述在合成一系列带有免疫显性T抗原二糖[β - D - 半乳糖 - (1 - 3) - α - D - N - 乙酰半乳糖胺]的糖树状大分子方面所取得的进展,该二糖存在于癌组织尤其是乳腺癌的恶性细胞上。这种抗原在健康组织上通常是隐蔽的,由于异常糖基化作用在癌细胞上大量增加。它被认为是一种重要的癌症标志物。这些癌组织通过转移侵袭其他组织如淋巴结、肺和肝脏的高发生率是制备T抗原树状大分子的一个理由,这种树状大分子可能在手术后具有阻断受体位点的潜力。将简要描述T抗原二糖的合成,随后阐述分别用于产生针对T抗原的单克隆抗体和用于筛选目的的新糖蛋白及糖聚合物。由聚(酰胺胺)(PAMAM)、聚(丙烯亚胺)、N,N'-双(丙烯酰胺基)乙酸以及最后超支化L - 赖氨酸制成的支架被用于构建带有T抗原部分的相对较小的糖树状大分子。少数糖树状大分子还与荧光素和生物素探针相连,以生成可用于检测T抗原受体位点的配体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验